Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |